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Preface

This paper has been written as a review of recent

literature on sulfonamide therapy in an attempt to show
just cause for reclassification of the so-called toxic

reactions and symptoms.

No attempt has been made to

exhaust all the lmowledge of all the different types of
reactions, but representative reports have been taken
and considered individually for their ability to en

lighten the confused conditions which surround these
reactions.

An enormous amount of literature is available to

the person interested in sulfonamides in general, tut

there is a deficiency of pertinent, factual__information

about the mechanisms involved in producing the reactions

which follow the use of sulfonamides.

Every attemp�

has been made to amass pertinent information with the

view in mind of clearly differ�ntiating between types

of reactions, and even more important, of understand

the mechanisms responsible for these reactions.

subject is far f'rom being settled.

The

It is well �own to the author that theories are

commonplace but they are the goals toward which sound
investigation are launched •
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INTRODUCTION

Disease producing bacteria can invade the tissues

ot the human body by penetrating the surface of a vulner

able portal of entry; then, becoming locally entrenched,

they propagate rapidly in their attempts to extend their
invasion into normal tissues.

For bacteria to multiply

within the tissues and fluids of the body, they must be
able to utilize the constituents of these media to

satisfy nutritional and respiratory requirements.

The

processes involved are a group of enzymatic reactions,
very much like those ot all living cells.

It is logical

to believe that disruption of one of these enzymatic

processes places the pathogen at a disadvantage in its

attempt to overcome the defensive barriers actively en-

gaged in the host.

In event of such an existing disease

process, specific measures are indicated, it available,
to destroy the invading micro-organisms or to effect

changes in the tissues which result in their destruction.
Among the most difficult problems in the prepar

ation and selection ot an agent to destroy micro-organ
isms present in the body tissues, is that-of toxicity
to body cells. Most efficient bactericidal and anti

septic agents are equally efficient in their destruction
of body tissues.

This problem of t�xicity has giiided

medical research in the preparation of anti-bacterial

agents having specificity for the pathogen·or its prod
ucts.

Among the products of such investigation are the

sult'onamide group of drugs.

Numerous theories have been proposed to explain the

mechanism of anti-bacterial action of the sulfonamides.

More advanced research has produced much evidence that
the nutrition cycle of the pathogen is disrupted by

interfering with a specific enzymatic process, leaving

the micro-organisms at a static level of growth. Long
and Bliss state,'' it seems possible to conclude that
,

sult'anilamide does not arouse a specit'ic response on_the

part ot' the host.

The production of antibodies is not

stimulated, and there is no direct action upon the phag

ocytic mechanism.

On the other hand, there is.consider

able evidence that the drug does act upon the micro-org

anism in vitro and in vivo.

Most workers believe that

this action takes the form of an inhibition ot' the growth

of the bacteria, which brings about a suppression of

their invasive power, and which, thereby, permits the

defense mechanism of the host to accomplish its tunction."l
Thorough knowledge of the therapeutic activity and

mode of action is extremely valuable in explaining the

occurrence of undesired reactions attributed to sulfon
amide drugs.

Progress has been made with the discovery

and identification of certain substances, which, when
2

present in the media, will strongly antagonize sulfon
amide bacteriostasis.

Small amounts of a product ob

tained by enzymatic digestion of proteins significantly
diminishes the bacteriostatic effect of sulfonamides in

human serwn.

Such substances provide an excess source

of easily assimilable nitrogen which interferes with
sulfonamide activity.

This phenomenon is
easily
demon.
.

strated clinically by observing the inability of sulfon
amides to inhibit the growth of pathogenic bacteria
present in an area of necrosis.2

�e basic assumption postulates that para-amino
benzoic acid is an essential growth substance for bact
erial cells and quite possibly for other living cells.
Sulfonamides bear such close resemblance.to para-amino

benzoic acid that it competes with the essential

metabolite in combining with a particular molecular

grouping on the surface of the bacterial protoplasm.
This substance is capable of inhibiting the therapeutic
effect of all of the sulfonamides regardless of the

differences in structure. Also, the amount of para
a.mino-benzoic acid required to prevent therapeutic

activity was found to be in direct ratio to the bacter
iostatic strength of the drug, other variables being
held constant.

These findings support the. contention

that the effect of sulfonamides is basically due to the

3

para-amino-benzoic acid structure which is common to
all of the sulfonamides.3

The fact that pathogenic

organisms which become resistant to one of the sulfon

amides are comparably resistant to the action of the
related compounds also supports this concept.4

There is little doubt but that the action of the

sulfonamides is one of inhibition rather than direct
action.

They allow bacteria to grow in serum for a

short time, and then rather abruptly stop the logarith

mic increase in growth.

A level of population is held

much below that which the medium is capable of support

ing. Th.is action is reversible, for at any point short
of complete bacterial death, the organisms regain :full

growth activity when transferred to a sulfonamide-:f.ree
medium.2

·Sulfonamide drugs were introduced into medicine

as specific treatment for diseases caused by the hemo

lytic strains of streptococci and the pneumococci.

Previous to this introduction, no specific treatment

was known for these diseases with the exception of anti
sera. However, at the present time, other drugs are

known and used with equal efficiency.

This situation

demands an appraisal of the merits and demerits of the

sulfonamides and suitable limitations standardized for
their use •
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DISCUSSION
I.

Sulf'onamide drugs are known to cause a variety of'

undesired manifestations in humans which vary in sever

ity f'rom mild malaise to prostration and even
. .death.
As a general rule, with some exceptions, the reactions

appearing early in the first course of' sulfonamide ther
apy are mild and the later reactions are more severe.

No clear-cut evidence has been produced to explain this
condition.

The following discussion differentiates the

various reactions according to mechanism of' production
and the time at which they become manifest.

Within a very few hours after the initial oral

administration of' a sulfonamide, the patient may exper
ience a moderate degree of' nausea, tinnitus, malaise,
headache, and mental confusion.

The incidence of' these

symptoms is greater f'ollowing the use of' sulf'anilamide.

These symptoms are usually not severe enough to warrant

the discontinuation of' therapy and in nearly every case,
they disappear completely in a very short time.

The

mechanism involved in the production of' these symptoms

is unknown.

Parenteral administration is accompanied

by these complaints in·the same percentage of' incidence.

This leads to the belief' that sulfonamides are capable
of' exerting a direct toxic action on the central ner

vous system.5

5

Isolated cases have been reported in which a toxic

type of psychosis has developed. Closely obser.ved cases

show that these severe symptoms appear only after the

blood level of sulfonamide exceeds a specific value and
disappear shortly when the blood level again recedes to
some value below the critical level.

varies with the patient.

The critical level

Permanent damage may be sus

tained, if the critical blood level is exceeded for a

period of several days.6,7

Cyanosis freouently follows the use of sulf'anilamide,

but is less comnonly seen following the use of the other
sulf'onamides.8

This condition is not known to be a true

cyanosis and the mechanism of production is not clearly
understood.

It usually appears early in the course of

therapy and is in no way related to massive doses of the

drug. Colebrook and Kenny assumed. the presence of sulf'

hemoglobin to be the source of the chocolate-brown color
of the blood.9 Subsequent spectroscopic studies'of this

discolored blood failed to show the presence of more than

a doubtful trace of sul:fhemoglobin.10

Marshall has found

a moderate amount of methemoglobin in the blood of these
patients, but believes the amount to be too small to

cause clinically apparent cyanosis.

Associated with this

belief is the fact that these patients may be extremely

cyanotic, but almost 100% of the hemoglobin is functional
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and that in a few cases no methemoglobin is found.

Thus,

it was suggested that the dark brown color of the blood

is the result of a dye formation capable of staining the
red blood cells.11 Of interest, is the notation by

Ottenburg and Fox that dilute sulfanilamide solutions
will develop a violet color following brief exposures

to ultraviolet light.

It was determined that the red

blood cells may absorb or adsorb this violet substance.

This projects their opinions that the colored derivatives
of sulfaniiamide and related compounds were the. factors

involved in the production of an appar�nt cyanosis.l

·considerable confusion exists with reference to the

production of acidosis by sulfonamides. Some invest

igators-have shown that following the ingestion of sulf
anilamide, there is an increase in sodium excreted in

the.urine and a marked reduction in ammonia output, re-

·sulting in a more alkaline urine. Associated with this
fall in serum sodium is a decrease in carbon· dioxide
combining power of the plasma.

In cases where the fall

in carbon dioxide combining power was large, a definite

hyperpnea was noted and an uncompensated acidosis was
established.

This concept has been the basis for the

administration of sodium bicarbonate concurrently with
sulfonamides.12

In distinct opposition to this view are

those who believe that sulfanilamide causes a hyper-

7

ventilation type of alkalo.sis and that further alkali

therapy increases the degree of uncompensated alkalosis.

They found a rise of pH and bicarbonate content in the·

urine and a fall in carbon dioxide content of the serum.

Sodium r lactate was advised as concurrent therapy since
there was an existing carbon dioxide deficit.

Ketosis

and lactic acid accumulation were likely to result, and ·
should the hyperventilation cease abruptly, this would

allow carbon dioxide to accumulate.1,5 Beckman and

Bauer reported the results of their experiment showing

that there was a sharp drop in alveolar tension.of carbon

dioxide, a sharp rise in serum pH, and a moderate rise in

urinary pH and bicarbonate.

They concluded that sulfanil

amide produces a primary alkali deficit type of acidosis.

It is known that the -S�Nfi2 radical of sulfanilamide in

activates carbonic anhydrase and this has been offered as
an explanation for the acidosis.

The collected evidence

shows that acidosis produced by sulfonamides is not

severe and is temporary, therefore, clinical observers

choose individually between alkali therapy or no alkali'
therapy.l,13

Clinical experience with the sulfonamides has shown

that among toxic effects referable to the urinary-system,

the most conmen are hematuria, renal colic, and anuria or
oliguria.14 Renal colic is due, no doubt, to the form8

ation of concretions and obstruction to the flow of urine.

Anuria or oliguria occur in conjunction wi�h renal colic,
but may occur alone.

Hematuria is considered a sign of'

glomerular irritation or hemorrhage from the vessels close

to the lumina of urinary passageways.18,15 Among the sev

eral factors influencing the deposition of urinary con

cretions, most important are concentration of' the drug in
the urine, degree of' acetylation, urinary stasis, pH of
the urine, and temperature.

The acetylated sulfonamides

are less soluble than the free forms of the drug, and as

a �esult, those drugs which are acetylated to a greater
degree are the more con:mon offenders.

There is no known

method available to aid in diminishing this process.

Reabsorption of water in the urinary tubules increases
the concentration of the drug in the urine to a point

where precipitation occurs.

Concentrations of' the drug

in the blood are, within limits, proportional to those in
the urine, this
crystals.

being

the major factor in the formation ot

Crystals may appear anywhere in the urinary pass

ages and concretions or masses of' crystals tend to form
which obstruct the flow.of urine.

These drugs are more

soluble in alkaline urine and a decrease in pH of' the urine

could be a primary factor, though it is more comnonly con

sidered a factor which increases the amount of' precipitated

crystals.

Changes in temperature have some effect on the
9

solubility of these excreted drugs, but are not of pr:lin
a:ry importance, since the changes of temperature within
the body are minimal from �his viewpoint.

It is well

known that urinary stasis resulting from _collections of
crystals enhance the formation of cor1cretions, and free

flow of urine is necessary to carry the crystals from

their site of :fonnation and eliminate them from the body.

15,14,16,16,17

It is extremely interesting to note that patholog

ical reports :from the kidneys of children indicate that
crystallization

of sulfonamic:1.es in the urinary passages

is not the sole picture. Anuria and hematuria were

attributed to an acute necrosis of the epithelium of the
proximal convoluted tubules.

Associated findings were

the presence of petechiae and ecchymotic areas in the

mucosa

of

the pelves of the kidneys. This may never

have been found in adult kidneys, but the fact remains,
that glomerular irritation is not always the cause of
hematuria following su.lfonamide therapy.18, 15, 19, 16
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II • .

'!'he oral administration or local application of a

sulfonamide drug may be accompanied by manifestations
of' intolerance.

Those reactions which are believed to

be due to a direct action of' the drug on the body tissues
have been discussed under toxicity. Aside from these

reactions are those which do not appear to be pure or

simple toxic reactions. At the present time, many invest

igators are reporting cases which closely parallel those

known to be of an allergic nature. Admittedly, no one
has determined the mechanism of production, and con

sequently, no one has proven these reactions to be true
allergic or hypersensitive responses.

The f'o_llowing re

sume is an attempt to describe and classify these react

ions as being distinct from those discussed in section I.
Leftwich postulates the f'ollowing requirements in

classifying a reaction in the hypersensitive group:
1.

The occurrence of' a skin eruption, fever, or

conjunctivitis in the course of' therapy that is

not related to the original disease or due to a
2.

secondary process.

Complete and permal)ent disappeara11ce of these

symptoms upon discontinuation of' the sulf'onamide.

3. A time interval between the beginning of' sulfon
amide medication and the appearance of' hyper11

sensitive phenomena of at least six days, unless a hist
ory of previous administration of the drug was estab

lished.20

Lyons and Balberor report a series of cases which

are typical of hundreds of other reports on this partic
ular type of reaction.

They observed that some patients

who had been given one course of sulfathiazole without

deleterious effects, had fever shortly after the start of

a second course of the drug.

The fever appeared to be

associated with the administration of sulfathiazole rather

than with the infection for which the second course of the

drug was given.

VJh.en the drug was discontinued, the fever

subs�ded promptly. They found this type of response occur

ring in 36$ of their patients_ recieving a second cours� 6
sulfonamides and presumed that it was due to a hypersens
itivity to sulf'athiazole.

The reactions occurred on the

first day of the second course and was characterized by a

sharp rise in temperature to between 1020 to .1060 Fahren
heit. After the drug_ was discontinued, the temperature

returned to normal within an average time of three days.

Associated with the fever were profound prostration, weak
ness, and exhaustion which were out of proportion to the

amount of temperature elevation and the genera� clinical

appearance.

In. order to satisfy their belief that this

phenomenon was

a clinical
12

entity, they attempted to re-

produce an identical response by giving further courses

of sulfonamides to patients having experienced a :febrile

reaction :formerly.

Ten patients, who had experienced a

thermal response to the second course of sulf'athiazole

were given a third course in an attempt to reproduce the
reaction. An average of seventeen days was allowed to

elapse after the previous reaction had subsided, before

the third course was begun. Eight o:f these patients had

identical reactions almo�t imnediately.

In one selected

case, the patient received eight courses o:f sulf'athiazole

and after an uneventful initial course, experienced seven
distinct thermal reactions.

progressively less severe.21

The later reactions were

The incidence of these_ so-called hypersensitive

reactions to sul:fonamides has not been adequately deter

mined. Reports of the incidence of such hypersensitive
phenomena. vary from 2% to 36%. SUl:fanilamide, sul:fa
pyridine, and sul:fadiazine seem to.be offenders with

, approximately the same frequency.

Sulfathiazole is def

initely more capable o:f producing sensitization than the

other sulfonamid.es.20 There are no unmistakable diag
nostic features which allow the recognition of these

reactions in every case, and until such criteria is def

initely established, the data acquired will be of little

value in a statistical sense •
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Hospital records of two hundred consecutive cases

receiving sulfathiazole were examined �or the :frequency
of fever reactions during a single course of the drug.

Only five :patients experienced fever.

In no case was

fever produced before the seventh day.21 Another series
of 177 children was studied and the incidence of fever

during the second course of' sulfonamide amounted to 4%.
The initial courses
of both sulfathiazole and
sulfa.
.

diazine were unevent:fl.11, and the duration of the courses
varied f'rom two to forty-two days. Dosage maintained

during the initial course was½ to 1 grain per pound per
day.

None of the children developed an immediate therm

al response.

The conclusions derived were that previous

courses of sulfonamides do not appear to predispose the
patient to a higher incidence of febrile reactions.22

An important notation from the preceding series of' ped

iatric cases is the fact that from a group· of five cases,
entirely different results were obtained under slightly
different circumstances.

These five children experienced

toxic reactions during the initial course of therapy.

The second course of sulfonamide produced an inmlediate
type of febrile response with fever and skin eruption

within eight hourse.

In one of these cases, the reaction

was extremely severe, but fever subsided on the third day
in spite of the fact that the drug was continued.22
14

Dowling and Lepper collected a series of cases :from

which they attempted to answer the following questions:
Does a second course of sulfathiazole incur a greater
mmber of reactions than the other sulfonamides?

Is a

second course of the same sulfonamide more likely to

cause a reaction than if a different drug were used?

Is

this phenomenon related to the length of the first cou_rse
or the length of interval time? A series of 737 patients

were observed during a single course of therapy with sev
eral sulfonamides and 5% developed febrile reactions.

Among 144 patients receiving various sulfonamides for be
second time, 11.1% developed fever and associated mani
festations.

In respective series' of over fifty patients

each, sulfathiazole caused reactions in 16.7%, sulfadia

zine caused responses in 7.4%, and sulfapyrid�ne incurred

9.1% incidence of reactions when these drugs were given
for the second time. When a different sulfonamide was

used during the second course, the percentage was lowered.
Sulfathiazole caused reactions in 5.6%, sulfadiazine was

reported to be 0.5%, and sulfapyridine was reported to be

0.0% when different sulfonamides were administered during
the initial course of therapy.

The writers were unable

to find any correlation between the length of the first

course of therapy and the incidence of fever during the

second course. Febrile reactions were no more frequent
15

when the time interval between courses was short than

when it was long -- time being measured in terms of weeks

and mo�ths.23

In conjunction with the above findings,

Davidson and Bullowa report a case in which there devel
oped

an apparent

sensitivity to sulf'app-idine.

This pat

ient was given a subsequent course -of sulf'amethylthiazole

and responded with signs and symptoms of a hypersensitivity
reaction.

A subsequent course of sulfanilamide did not pro

duce a response of any type.

This pat:e nt was apparently

sensitized by his treatment with sulfapyridine to both the

sulfapyridine and the sulfamethylthiazole derivatives.

The symptoms which characterized these reactions were mild
generalized pruritus, generalized erythematous eruptions

on the face and chest, marked conjunctival injection, a

f'eeling of chilliness without an actual chill, and� rise
in temperature to 105.4°F.

These appeared within eight

hours after the beginning dose of the drug.24

Among these reports in the literature are several

series of cases pertaining to skin sensitivity as a result

of sulfonamides.

Livingood and Pillebury report reactions

in twelve patients which are typical of innumerable other
series.

The lesions were various forms of eczematous

dermatitis complicated by some degree of low grade sec�nd

a:ry pyococcic in:f'ection and they were treated for more than

five days with 5% sulfathiazole by ftocal application.
16

oral aaministration of sulfonamides resulted in a char
acteristic �xplosive type of systemic and dermatologic

reaction.

These patients were f'rom a series of 1000

cases suffering f'rom various dermatoses so treated with

sulfonamides.

The following points were common factors

in all of their cases:

The reaction occurred only in

�ose patients whose dermatitis was due to a sensitiza

tion to insect bites, wool, soap, allergenic products of

bacteria, etc.

The reactions were probably induced by

prolonged application of sulfathiazole ointment and be
comes manifest when sulfonamide is given by mouth.

The

symptoms occur within a verry short time following admin
istration of a very small amount of the drug.

The course

of events was very similar in all eases, such as, the

, prompt developnent of systemic symptoms - malaise, chill
iness, and fever.

There was a local exacerbation of the

lesions under treatment and the generalized eruption,

which was always pruritic and "explosive" in its onset.

The reactions d�creased in severity with repeated courses,
1n most cases.

There were no changes in the blood count

and no evidence of pathology elsewhere in the body.28,21,29 ·
Another series of.twelve cases are reported in which

local sulfonamide therapy caused sensitization dermatitis.
In all cases, the cutaneous hypersensitivity to sulfon

amides was apparently induced by their local application.

17

When this sensitization had taken place, the dermatitis

could be produced by both further local application and

internal administration of not only sulfanilamide which

was given in the original course, but by other related
drugs of the sulfonamide series.

Interestingly, the

reactions were proportional to the dose of the drug.and
to the degree of sensitivity.

In the same patient, a

large dose caused a very severe eruption, a·moderate dose
caused a mild eruption, and a small dose would of'ten go

winoticed. The reaction to oral administration was m�re
severe than to topical application. All of these cases

flared up on giving sulfanilamide by mouth, usually with
as little as one 0.5 gram tablet.

Four out of six cases

tested gave a reaction to sulfapyridine, but in rather

large doses. Of the twelve cases, six reacted to topical

application of the drug in the eczematous area where.the

original sensitizing applications were made. Other parts
of the skin were much less sensitive.

Even those areas

which became inflamed on oral administration of the drug
reacted to contact application in only one case.

Patch

tests on unaffected areas of the skin, therefore, would
not be of value in diagnosis of this condition.30

The cutaneous eruption of a hypersensitivity response

to sulfathiazole has been described as pa.pules or vesicles

proceeding to eczema.tization with erythema, oozing, crust18

•

formation, desquamation and healing without scarifica
tion.

The diagnosis is established only from the hist-

ory and by patch-testing.

Control patch tests should

be performed on non-sensitive patients
to exclude the
.

possibility of a primary irritant. Attempts to discover

an irritant or allergenic tendency among the bases for
the sulfonamide ointments have been unsuccessful.31

Greenwood believes it possible to classify the ef

fects of' the sulfonamides on cutaneous surf'aces into
three categoriesi

1. Direct effects due to overdose and cumulation.

These toxic findings are usually faint, finely
papular eruptions on the exposed surfaces and
often accompanied by mild pruritus and fever.

With continued therapy, the eruption spreads and
becomes maculo-papular, scarlatiniform, or morb
illiform.

There is no accompanying lymphadenitis.

The eruption fades when the drug is withheld and
of'ten it may be readministered wit h no untoward

2.

effects.

Purely all-ergic effects.

These are identical with

those seen in antigen-antibody reactions in protein
a.naphylaxis.

These reactions are identified by an

intense pruritus, sneezing, lacrimation, and dysp-

nea with edema of the lips, eyelids, and face dur19

ing early phases of the treatment.

The eruption

ma� be evanescent or hemorrt:iagic in type

and

patch tests may be positive.

3. Allergotoxic effects.

This is a peculiar sensi

tivity due to gradual sensitization as indicated

from the evidence presented. The accuracy of this
classification is not above reproach.

Effects of

this type usually appear :from the seventh to fouI'
teenth days in the course of sulfonamide therapy.

The eruption is maculo�papular and associated �th
pruritns

and

evanescent lesions.

Fever is coJmJ10nly

present as well as leucocytosis. Resumption of the
drug is quite certain to cause a recurrence of the
eruption and other symptoms.32

Shapiro and Block have cited two cases in which severe

renal complications followed a single intravenous inJect�on
of sodium sulfadiazine. · These patients had received prev
ious courses of sulfonamides with no ill effects.

In the

f'irst case, the patient had received only 5 grams of sodium
sulf'adiazine six months previously.
healthy at this time.

Thie man was apparently

Two and one-half hours after the

second course was begun, the patient complained of severe

pain in the region of _the costovertebral angles.

Four

hours after the injection, the patient passed about seven

cubic centimeters of sanguinous urine and experienced an
20

extremely severe sharp, localized pain over the kidners.

Fluids were given and one month later, kidney �nction
tests were normal.

In the second case, identical cond

itions existed, and the patient voided fifty cubic centi

meters of grossly bloody urine withing fifteen minutes

after the injection of five grams of sodium sulfadiazine.

Alkaline fluids were given and the symptoms disappeared
rapidly.
al.

One month late�, kidney function tests

were

ncrm

The striking evidence presented in these cases is the

rapidity with which the renal manifestations appeared.
The blood concentrations existing in these cases were
above 20 mg.%.

Similar drug levels were found in other

subjects studied by the investi�tors who did not develop

renal complications.25

Histologic findings have been reported that are not

in accord with the generally accepted belief that renal

failure after sulfonamide therapy is caused by mechanical
blockage of the urinary passages.

The most striking find

ings were present in the convoluted tubules, where severe

degenerative changes were observed and identified as

being similar to those changes seen in mercurial poison
ing.

Lehr and Antopol present similar findings that sup

port the belief that not all cases of renal damage follow

ing a second course of sulfonamide therapy are caused by
crystal formations. Richards presents . the
21

view

that poison-

ing of the tubular epithelium permits water to pass back

into the blood by simple diffusion.

In this manner, com-

, plete anuria may follow the administration of a tubular
poison through filtration in the glomeruli continues.

In

addition, hematuria assumed to be a manifestation of glo

merular irritation is in some cases due to loss of blood

fTom degenerative areas loce.ted in the convoluted tubules.
26 Erganian and Doval present these. postmortem findings
on a case which may be included in the same category as

those presented above: Fluid enclosed in the calices and

pelves; In the grayish white mucosa of the pelves were

petechiae, and on the mucosal surfaces were many small

yellow crystals with masses of crystals at the orifices
of the uretero-pelvic junctions. Microscopic examina

tions revealed moderate necrosis of the epithelium of the

tubules, expecially of the proximal convoluted tubules.

Hemorrlia.ge was evident beneath the mucosa and within the
adjacent tubules. There ,ra.s slight interstitial edema
in the cortex. An interesting associated finding was

the presence of several areas of focal necrosis in the
liver. The complete pathological diagnosis was acute

nephrosis with early regeneration of the tubular epith

elium, kidney calculi, hydronephrosis, and petechiae and
ecchymoses in the pelves of the kidneys.27,26
Typical lesions of periarteritis nodosa have been
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reported to follow sensitivity reactions to serum, and
in some cases, sulfonamides were given in combination
with the sera.

Investigation revealed similar lesions

resulting :from sulfathiazole therapy, but only, in those
cases in which a sensitivity reaction had occurred.

The

lesions consisted of fresh fibrinoid and hyaline necrosis
of segments of the walls of arteries with a moderate infiltration of inflammatory cells.
about the affected vessels.

There was hemorrhage

Eosinophils were present in

large numbers, and were absent in biopsy material taken
one month later.36
this view.

There is much evidence to support

The evidence indicates that different sens-

itizing antigens can effect the developnent of these vascular lesions in different patients.37
Rich reports a single case which was under ideal
· conditions for observing the relation of sensitivity to
development of periarteritis nodosa.

This patient had an

ulcer on the scrotum, later diagnosed as carcinoma.

Five

months after the initial biopsy, this patient was given
sulfathiazole pre-operatively and the lesion was excised.
The initial course consisted of 1,2,4,3 grams given orally
on four successive days, and then discontinued.

On the

eighth post-operative day, the patient complained of stiffness and pain in the neck and eyes.

On the eleventh

post-operative day, sulfathiazole was given both locally
23
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and orally. A febrile reaction occurred almost inmed

iately. Sulf'athiazole was contirmed until the sixteenth

pos�-operative day, and on the eighteenth post-operative

day, the patient

expired.

Microscopic examination of

autopsy tissues revealed widespread, fresh lesions of
periarteritis nodosa.

These vascular lesions were found

in the operative site,.heart, liver, spleen, kidneys,

testes, bladder, and prostate.

"Finally, there

were

present in the lungs, spleen, kidneys, and bladder very

mirmte focal necroses, densely inf'iltrated and surrounded

by monomiclear and polymorphonucleer cells including

eosinophils quite like those encountered by Lederer and

Rosenblatt, Merkel and Crawford, and

others

in patients

dying from a reaction following sulfathiazole therapy."

This case pres ents unmistakable evidence.

The vascular

lesions were in ear]J stages of developnent. Biopsy

material was obtained and examined five months before

sulfathiazole was given, at the time_of' operation which

was after the initial course of' sulfonamide, and at

autopsy which was nine days after the hypersensitive
reaction occurred.

There were no lesions of periarter

itis nodosa in the biopsy of the .scrotum or inguinal

nodes removed at the time of operation, but many such

lesions were found in the operative wound and in adjac
ent scrotal tissues at the time of' autopsy.36,38
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Little is known about the pathogenesis of acute

hemolytic anemia associated with sulfonamide therapy.
The

clinical evidence presented in regard to the incid

enC.e and nature of cases of acute hemolytic anemia is not

adequate for complete discussion.

It is clear from study

ing the blood of patients suttering :f'rom this type o-r

reaction that the drug acts either directly or indirectly
on the red blood cell causing hemolysis.

There is no

evidence that the anemia is in any way.related to the de

pression of the bone·IDa.ITow, for in all of the cases stud
ied, there have been signs of increased rather than de

creased hemopoiesis. However, no direct examinations of
the bone marrow have been reported.

Thus far,
it has been
'

impossible to reproduce the hemolysis by adding sulfanil- ·
amide to.the blood in vitro.

No sickle cell traits or

in

creased fragility of the red blood cells have been detect
ed in any of the cases. Acute anemia associated with

sulfonamide therapy must be classed as a drug idiosyncrasy
especially in view of the fact that the majority of pat

ients who have once suffered an attack appear to be sus

ceptible to recurrent attacks with subsequent courses of
sulfonamide therapy.

The exact mechanism whereby the drug

causes hemolysis must await :further study o� the blood of
susceptible persons.34,35,39,40

Acute hemolytic anemia which results during the ad25

ministration of the sulfonamide compounds differs strik
ingly from the mild hemolytic anemia which develops so

commonly following an initial course of sulfonamide ther

apy.

It is rapid in its onset and course, and its effects

are often of a violent nature, sometimes being fatal.

Since the incidence of this type of reaction is so un

common, it has been thought to be the result of an idio

syncrasy or allergy.33 • The appearance of spherocytosE

and increased bypotonic fragility in experimental and

acquired hemolytic anemias has been assumed to be an

inherent fault in red cell formation in the bone marrow.

This

view

has been disproved. 34

It has been shown that

the spherocyte is a mature red cell which has been in
jured by the activity of a hemolytic agent.

Thus, spher

ocytosis, which was thought to be pathognomonic of acute

hemolytic syndromes of a familial type, may occur in

other types of hemolytic syndromes and in the initial and

active stages of the acute hemolytic reactions associated
with the sulfonamide compounds.33

From the studies of

Watson and Spink, as well as those of Ham and Antopol,
Goldman and Sampson, it is now evident that profound

changes occur in the hemoglobin metabolism in the red

blood cells of patients receiving sulfanilamide. Evidence

of �creased blood destruction and changes in fragility

to varying concentrations of salt solutions has' been ob26

tained and suggests that sulfanilamide, in some mysterious

way, makes the red blood cells vulnerable to rapid destruct
ion. At the same time, it has a profound. effect on the

bone marrow causing the changes that are responsible for
the effects which are identical with hyperleukocytosis
with leukemoid reaction.

Of great significance is the

observation that a recurrence of the anemia may follow

the second course of the drug and that this reaction is

very much like a hypersensitivity reaction.1s,34,35,39,40,46,47
Investigation directed toward finding the relation

ship of neutropenia and sulfonamide therapy has be�n

thoroughly evaluated by Long and Bliss. A review of 33

cases so reported by Bigler and associates failed to sub
stantiate their view that su;t:rona:mides were capable of

depressing the white blood cell.count of peripheral blood •
Britton and Hawkins reported occasional instances in

which a transient leukopenia developed during sulfonamide

therapy. Absolutely no relationship was established be

tween toxic manifestations of the drug and the variation

in the white blood cell counts in these patients.

In a

series of 408 cases, none presented significant changes

in the white blood cells which could be attributed to the

toxic effects of sulfonamides.

Their conclusions include

the view that in patients suffering from agranulocytosis
and concurrent infections, sulfonamide therapy may be a
27

lite-saving procedure.I Kee"'fer introduces the report

that agranulocytosis may infrequently follow sulfonamide
therapy, but this condition always occurs between the

second and third week of therapy.15

Neutropenic states have been produced by admin

istration of benzene and other drugs with a benzene, ring

in their makeup. Sulfonamides tall into this group o�
drugs.

Some authors state that agranulocytosis appeared

on1y a�ter these drugs came into use. Several cases are
reported in the literature in which agranulocytosis
followed amidopyrine.

It is the opinion of some invest

gators that small repeated doses of the drug caused ·the

neutropenia to recurr inmediately in each case, a.nd they
concluded that this condition was manifest as a drug

allergy.

In 1938, Kracke found that this disorder

occurred only is susceptible people, �d that in these
cases, the reaction was caused by amidopyrine and its
closest chemical relatives.

Park believes that sulfon

amide neutropenia,is acquired, since it appears only afier
an interval period of at least a week.

These drugs are

so rapidly excreted that in order to maintain an ade.quate

blood concentration, they must be given :f'requently in
d�ses totaling at least six grams a day.

Thus, accumu

lation could not possibly have occurred in these cases;
,,

and moreover, reactions have followed small doses long
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a�ter all traces of the drug must have been eliminated.

Also, the- condition is specific.

No cases have been re

ported of sulfonamides sensitizing patients to other

drugs capable of causing neutropenia.

The allergic

effects of drugs are recognized as being entirely dis

tinct from their toxic actions.

Toxic manifestatio ns

are characteristic for each individual drug and allergic
effects are comnon to a number of drugs, and their char
acter depends on the site of the reacting tissue.

Thus,

the leucopoietic marrow reacts in an identical fashion

to sensitization by sulfonamides, amidopyrine, arsphen

amine, and other benzene compounds.43,44,45

•

29.

CONCLUSIONS

The foregoing portion of this pa.per is a brief

compilation of reports referring to the undesired symp

itoms which often result from the use of sulf'onamides.

From the evidence presented, an attempt will be �onsidered
to classify the different types of reactjons and, if poss

ible, lend a view on the mechanisms of production of these

symptoms.

It seems logical to conclude that the symptoms dis

cussed in the first section are distinct entities that do

not appear together with any remarkable frequency.

There

is one thing, however, which is conunon to all of them.

These. symptoms are the result of a sulfonamide drug acting

directly to create pathologic or physiologic disturbance.

It is a known fact that drugs, and especially those of

synthetic composition, interfere with physiological pro

cesses within the body, when a therapeutic dose is admin

istered.

This interference may be a des�red consequenc�,

but the production of side-effects of such a therapeutic

process are not so desirable.

These side-effects are a

direct toxic type of manifestation.

The side-effects under-consideration are ear-marked

by the following sumna.ry of evidence as being the results
of a direct type of interference.

These symptoms appear

during the initial course of therapy.
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They appear during

the first few days of therapy when contri�utory factors

are present, as is the case with urinary calculi.

Very

small doses are capable of producing these effects, with

the exception of urinary calculi.

OVerdosage is capable

of increasing the symptoms ·as to severity and decreasing
the time of onset.

There is no proven relationship be

tween the symptoms under discussion.

For example, nausea

and vomiting appear shortly after the initial dose of

drug.

There is absolutely no conformity between the

appearance of these symptoms and urinary calculi or acid

osis. Each reaction is a distinct entity and when they

appear together, which is unconnnon, one must be consider

ed as being superimposed on another.

Two distinctly dif

ferent mechanisms are in action at the same time. A

second course of therapy, of'ten-times, is given when the

patient is in a different phyiologic state and no toxic

manifestations become apparent. Also, these reactions

may occur after the fif'th or sixth day of therapy, but
this is not characteristic or common. An overdose of

these drugs undoubtedly increases the incidence of side

effects, but this does not indicate any difference in the

mechanism involved in the production of' the toxic reaction.

This indicates that the mechanisms involved are more

active and a higher degree of tolerance is required if' the
patient is to be symptom-free.
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It must be borne in mind

that in every person receiving sulfonamides this mechan
ism is at work, although the reaction may not be severe

enough to elicit clinically apFent symptoms.

The reactions discussed in the second section of

this paper dif'fer in many respects f'rom those known to be

toxic in nature. These reactions are characterized by
far different symptoms with a different percentage of
incidence.

The usual time of' appearance is one of the

main reasons �or differentiating between reactions.

In fact, the time element and sudden onset of sym_ptoms

indicates a similarity to antigen-antibody reactions.

It is extremely interesting to compare these syn

dromes and determine the possibility of relationship.

Is it within the realm of possibility for sulf'onamides

to arouse sensitization? A foreign prote'in or protein

complex is the sensitizing and exciting agent responsible
f'or the condition known as allergy, which is an antigen
antibody reaction.

Landsteiner has proven the antigenic

qualities of proteins to which the azo-compounds have

been added. He has also proven the specificity of' these
conjugated antigens, �d the fact, that the haptene or

sulfonamide conjugant may play the role of' an excitant.48

Furthe� requirements must be satisfied, however, before

•

these reactions can be classified as sensitivity responses.

Of' 200 cases receiving a single course of therapy, 2.5%
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had drug fever. No case occurred before the seventh day.

Keefer makes the f'ollowing report: Fever occurs bef'ore the
sixth day or after 'the thirteenth day.

It is obvious

that he ref'ers to fever occurring af'ter the thirteenth day

of the initial course of' sul:f'onamide or be:f'ore the s ucth
day with subsequent courses.

In fact, this report is

almost identical :f'or skin eruptions, hemolytic anemia,

neutropenia, and icterus.15 During t.he second course of
therapy, 36% developed febrile reactions, and none of'
these patients experienced fever during the initial

course of' therapy. Ten of these patients were given re
peated courses of' therapy, and each time, the reactions

occurred suddenly before the fifth day of' therapy. Each
time the drug was given a reaction occurred.

Those cases

in wh ieh the time interval between courses of' therapy

was greater experienced more severe reactions. Those.

cases receiving multiple·eourses of' therapy with repeated

febrile reactions were noticed to experience less severe
reactions with each successive course.

In those cases in

which the drug was contiIDled, the reactions subsided in
spite of the fact that the drug was not�withdrawn.

Associated with the above findin gs are those of a

cutaneous type of reaction. These reactions are found to
occur in a greater percentage of' incidence in those sub
jects having an allergic tendency. These reactions
33
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occurred explosively during both the first and second
courses of therapy.

This apparent sensitivity can be

established by both local and oral administration of the
drug.

The severity of the reaction is related to the

a.mount of drug given previous to the reaction - the excitant dose.

An extremely small a.mount of the drug is

capable of producing a reaction.

Patch tests, using

serum from a subject receiving sulfonamide, are found to
be positive in these cases, if applied to those areas
on which the eruption appears.

In all of these cases,

there is an associated febrile response and marked
malaise.

The possibility of cutaneous sensitivity to

sulfonamides is accepted by dermatologists to be a fact.
49.

Periarteritis nodosa has been adequately shown to
be a product of a sensitivity reaction by evidence reportin the second section of this paper.
Thus far, it is difficult to discount the basis for
believing that the above reactions are sensitivity reactions.

This qualifies the classification.
There is an alteration ~n tissue reactivity in the

condition known as allergy.

This.alteration in sensitiv-

ity is the .result of exposure to- a specific substance,
so that upon re-exposure to the same or a closely related
substance a difference in reactivity is elicited.
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In

this instance, the reactivity is increased.

This con

dition must be specific and acquired. There are certain

typical stages by which a sensitivity state develops, re

gardless of the character of' the allergen. An initial

exposure to the allergen elicits no reaction in the tis
sues. After a varying incubation period - usually be

tween six and twenty days - the change in sensitivity

has developeq.

Should the allergen still be in the body,

e.g., continuously administered drugs, there is known

to occur a reaction known as the "spontaneous flare-up."
From that time onward, re-exposure will :lnmediately

elicit this sensitivity reaction, with no incubation

period required.49 This is ample evidence for the be

lief that those undesired reactions occurring after the
first few days of' the initial course of' therapy are
sensitivity reactions.

Thus, with more decisive invest

igation in the field of' sulfonamide therapy, many of_ the

so-called "toxic" reactions will be proven-beyond doubt
to be hypersensitivity responses. 'l'fhen the incubation

period i� definitely established, we will know whether
or not late sulfonamide reactions are toxic.

From the

evidence now obtainable, the incubation period should

be about six to ten days •

•
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